Vol 5, No 2 (2025): February

decorative image of the issue cover

Reimbursement Recommendations

Zilucoplan (Zilbrysq)

CDA-AMC

Published February 11, 2025

PDF HTML

Reimbursement Reviews

Baricitinib (Olumiant)

CDA-AMC

Published February 7, 2025

PDF HTML

Lebrikizumab (Ebglyss)

CDA-AMC

Published February 11, 2025

PDF HTML

Abemaciclib (Verzenio)

CDA-AMC

Published February 7, 2025

PDF HTML

Health Technology Reviews

High-Dose Bupropion for Depression

CDA-AMC

Published February 6, 2025

PDF HTML

View All Issues